Pure Bioscience Valuation
| PURE Stock | USD 0.05 0.00 0.00% |
Pure Bioscience seems to be overvalued based on Macroaxis valuation methodology. Our model determines the value of Pure Bioscience from analyzing the company fundamentals such as Shares Outstanding of 111.36 M, operating margin of (1.98) %, and Return On Equity of -1.29 as well as examining its technical indicators and probability of bankruptcy. . In general, most investors support purchasing undervalued entities and exiting overvalued entities since, at some point, asset prices and their ongoing real values will merge together.
Overvalued
Today
Please note that Pure Bioscience's price fluctuation is out of control at this time. Calculation of the real value of Pure Bioscience is based on 3 months time horizon. Increasing Pure Bioscience's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Pure otc stock is determined by what a typical buyer is willing to pay for full or partial control of Pure Bioscience. Since Pure Bioscience is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Pure OTC Stock. However, Pure Bioscience's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.05 | Real 0.042 | Hype 0.05 | Naive 0.0497 |
The real value of Pure OTC Stock, also known as its intrinsic value, is the underlying worth of Pure Bioscience OTC Stock, which is reflected in its stock price. It is based on Pure Bioscience's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Pure Bioscience's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Pure Bioscience helps investors to forecast how Pure otc stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Pure Bioscience more accurately as focusing exclusively on Pure Bioscience's fundamentals will not take into account other important factors: About Pure Bioscience Valuation
The otc valuation mechanism determines Pure Bioscience's current worth on a weekly basis. Our valuation model uses a comparative analysis of Pure Bioscience. We calculate exposure to Pure Bioscience's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Pure Bioscience's related companies.PURE Bioscience, Inc. develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. PURE Bioscience, Inc. was incorporated in 1992 and is headquartered in Rancho Cucamonga, California. PURE BIOSCIENCE operates under Household Personal Products classification in the United States and is traded on OTC Exchange. It employs 10 people.
8 Steps to conduct Pure Bioscience's Valuation Analysis
OTC Stock's valuation is the process of determining the worth of any otc stock in monetary terms. It estimates Pure Bioscience's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of otc stock valuation is a single number representing a OTC Stock's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Pure Bioscience's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Pure Bioscience's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Pure Bioscience's revenue streams: Identify Pure Bioscience's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Pure Bioscience's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Pure Bioscience's growth potential: Evaluate Pure Bioscience's management, business model, and growth potential.
- Determine Pure Bioscience's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the OTC Stock's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Pure Bioscience's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Pure Bioscience Growth Indicators
Investing in growth stocks can be very risky. If the company such as Pure Bioscience does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 88 M | |
| Retained Earnings | -129.3 M |
Complementary Tools for Pure OTC Stock analysis
When running Pure Bioscience's price analysis, check to measure Pure Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pure Bioscience is operating at the current time. Most of Pure Bioscience's value examination focuses on studying past and present price action to predict the probability of Pure Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pure Bioscience's price. Additionally, you may evaluate how the addition of Pure Bioscience to your portfolios can decrease your overall portfolio volatility.
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |